Product Code: 978-1-68038-125-2
Medical Gas Market Growth & Trends:
The global medical gas market size is estimated to reach USD 25.55 billion by 2030, expanding at a CAGR of 8.32% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rapid rise in the prevalence of chronic diseases, which necessitates the use of medical gases at various stages of disease management and control, is a major factor driving the market forward. According to the WHO, there has been a significant increase in the prevalence of diabetes, heart disease, and other non-communicable diseases worldwide over the last two decades. For instance, as per the CDC data, in 2018, 51.8% of US adults suffered from at least 1 chronic condition, and 27.2% had multiple chronic conditions.
Medical gases are an important component of many long-term care treatments for chronic conditions, and thereby rising prevalence of these diseases is expected to drive the growth of the medical gases market in the coming years. Furthermore, increased demand for advanced medical gas equipment such as vacuum systems and manifolds, are expected to drive market growth. For instance, Powerex is the first manufacturer of medical gas systems to test and certify manifolds. In addition, lately, healthcare has been evolving toward personalized medicine, DIY healthcare, and the homecare model, driven by technological advancements and financial pressure. This dramatic shift has created some significant opportunities in the medical gases industry. Home oxygen therapy, respiratory treatments, sleep therapy, and positive airway pressure devices have all increased demand for medical gases, and this is expected to continue over the next decade.
Medical Gas Market Report Highlights:
- Based on product, the pure gas segment dominated the market with a share of 56.80% in 2024 owing to the presence of a huge patient base suffering from respiratory disorders, and increasing number of patients requiring emergency medical care
- Based on application, the therapeutic segment held the largest market share over the forecast period. This is owing torise in the number of chronic diseases, and an increasing geriatric population
- The hospital segment dominated the market and accounted for a revenue share of 26.75% in terms of revenue and it is also expected to grow at the fastest CAGR of 8.89% during the forecast period.
- North America dominated the market and accounted for the highest revenue share of 35.65% in 2024. The growing awareness about chronic diseases, rising adoption of technologically advanced therapeutic and diagnostic products is projected to contribute to the regional market growth
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary Applications
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Applications
- 1.9. List of Primary Applications
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
Chapter 3. Medical Gas Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising chronic respiratory diseases such as COPD and asthma
- 3.2.1.2. Growing number of surgical procedures
- 3.2.1.3. Expansion of hospitals and healthcare facilities
- 3.2.1.4. Growth of Emergency Medical Services (EMS)
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High capital investment
- 3.2.2.2. Supply chain issues
- 3.2.3. Market Opportunity Analysis
- 3.2.3.1. Technological advancements
- 3.2.3.2. Growing strategic initiatives
- 3.3. Medical Gas Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
Chapter 4. Medical Gas Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 4.1. Medical Gas Market: Product Outlook and Key Takeaways
- 4.2. Medical Gas Market: Product Movement Analysis
- 4.3. Medical Gas Market Estimates & Forecast, by Product (USD Million)
- 4.4. Pure Gases
- 4.4.1. Pure Gases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1.1. Medical Air Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1.2. Oxygen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1.3. Nitrous Oxide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1.4. Nitrogen Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1.5. Carbon Dioxide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.1.6. Helium Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Gas Mixtures
- 4.5.1.1. Gas Mixtures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.1. Aerobic Gas Mixtures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.2. Anaerobic Gas Mixtures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.3. Blood Gas Mixtures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.4. Lung Diffusion Mixtures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.5. Medical Laser Mixtures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.6. Medical Drug Gas Mixtures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.1.7. Other Gas Mixtures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Medical Gas Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 5.1. Medical Gas Market: Application Outlook and Key Takeaways
- 5.2. Medical Gas Market: Application Movement Analysis
- 5.3. Medical Gas Market Estimates & Forecast, by Application (USD Million)
- 5.4. Therapeutic
- 5.4.1. Therapeutic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Diagnostic
- 5.5.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Pharmaceutical Manufacturing
- 5.6.1. Pharmaceutical Manufacturing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Other Applications
- 5.7.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Medical Gas Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)
- 6.1. Medical Gas Market: End Use Outlook and Key Takeaways
- 6.2. Medical Gas Market: End Use Movement Analysis
- 6.3. Medical Gas Market Estimates & Forecast, by Application (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Ambulatory Surgical Centers
- 6.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Home Healthcare
- 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Pharmaceutical And Biotechnology Companies
- 6.7.1. Pharmaceutical And Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Diagnostic and Research Laboratories
- 6.8.1. Diagnostic and Research Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.9. Academic and Research Institutions
- 6.9.1. Academic and Research Institutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Medical Gas Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 7.3. North America
- 7.3.1. U.S.
- 7.3.1.1. Key country dynamics
- 7.3.1.2. Regulatory framework/ reimbursement structure
- 7.3.1.3. Competitive scenario
- 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.2. Canada
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/ reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.3. Mexico
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework/ reimbursement structure
- 7.4.1.3. Competitive scenario
- 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. France
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Italy
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.5. Spain
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.6. Norway
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. India
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. Australia
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.7. Latin America
- 7.5.8. Brazil
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Regulatory framework/ reimbursement structure
- 7.5.8.3. Competitive scenario
- 7.5.8.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.9. Argentina
- 7.5.9.1. Key country dynamics
- 7.5.9.2. Regulatory framework/ reimbursement structure
- 7.5.9.3. Competitive scenario
- 7.5.9.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. MEA
- 7.6.1. South Africa
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Saudi Arabia
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. UAE
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Kuwait
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework/ reimbursement structure
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Recent Developments & Impact Analysis by Key Market Participants
- 8.3. Company Market Share Analysis, 2024
- 8.4. Key Company Profiles
- 8.4.1. Air Liquide
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Linde PLC
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Atlas Copco Group
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. INOX-Air Products Inc.
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. TAIYO NIPPON SANSO CORPORATION
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. MATHESON TRI-GAS, INC.
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. HORIBA Group
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. SOL India Private Limited
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Messer SE & Co. KGaA
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives